Papers
Topics
Authors
Recent
Search
2000 character limit reached

Improving Opioid Use Disorder Risk Modelling through Behavioral and Genetic Feature Integration

Published 19 Sep 2023 in q-bio.QM, cs.CY, and cs.LG | (2309.10837v2)

Abstract: Opioids are an effective analgesic for acute and chronic pain, but also carry a considerable risk of addiction leading to millions of opioid use disorder (OUD) cases and tens of thousands of premature deaths in the United States yearly. Estimating OUD risk prior to prescription could improve the efficacy of treatment regimens, monitoring programs, and intervention strategies, but risk estimation is typically based on self-reported data or questionnaires. We develop an experimental design and computational methods that combine genetic variants associated with OUD with behavioral features extracted from GPS and Wi-Fi spatiotemporal coordinates to assess OUD risk. Since both OUD mobility and genetic data do not exist for the same cohort, we develop algorithms to (1) generate mobility features from empirical distributions and (2) synthesize mobility and genetic samples assuming an expected level of disease co-occurrence. We show that integrating genetic and mobility modalities improves risk modelling using classification accuracy, area under the precision-recall and receiver operator characteristic curves, and $F_1$ score. Interpreting the fitted models suggests that mobility features have more influence on OUD risk, although the genetic contribution was significant, particularly in linear models. While there exist concerns with respect to privacy, security, bias, and generalizability that must be evaluated in clinical trials before being implemented in practice, our framework provides preliminary evidence that behavioral and genetic features may improve OUD risk estimation to assist with personalized clinical decision-making.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (71)
  1. NIH National Institute on Drug Abuse, “Overdose Death Rates ,” Jan. 2020, accessed on 2022-11-27. [Online]. Available: https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
  2. W. Yu, J.-X. Hao, X.-J. Xu, and Z. Wiesenfeld-Hallin, “The development of morphine tolerance and dependence in rats with chronic pain,” Brain research, vol. 756, no. 1-2, pp. 141–146, 1997.
  3. D. S. Hasin et al., “DSM-5 criteria for substance use disorders: recommendations and rationale,” American Journal of Psychiatry, vol. 170, no. 8, pp. 834–851, 2013.
  4. K. E. Vowles et al., “Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis,” Pain, vol. 156, no. 4, pp. 569–576, Apr. 2015.
  5. S. P. Stumbo, B. J. H. Yarborough, D. McCarty, C. Weisner, and C. A. Green, “Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement,” Journal of substance abuse treatment, vol. 73, pp. 47–54, 2017.
  6. C. Li, L. Qu, A. J. Matz, P. A. Murphy, Y. Liu, A. W. Manichaikul, D. Aguiar, S. S. Rich, D. M. Herrington, D. Vu et al., “Atherospectrum reveals novel macrophage foam cell gene signatures associated with atherosclerotic cardiovascular disease risk,” Circulation, vol. 145, no. 3, pp. 206–218, 2022.
  7. A. Giannoula, A. Gutierrez-Sacristán, Á. Bravo, F. Sanz, and L. I. Furlong, “Identifying temporal patterns in patient disease trajectories using dynamic time warping: A population-based study,” Scientific reports, vol. 8, no. 1, pp. 1–14, 2018.
  8. S. W. Choi, T. S.-H. Mak, and P. F. O’Reilly, “Tutorial: a guide to performing polygenic risk score analyses,” Nature protocols, vol. 15, no. 9, pp. 2759–2772, 2020.
  9. N. Mavaddat et al., “Polygenic risk scores for prediction of breast cancer and breast cancer subtypes,” The American Journal of Human Genetics, vol. 104, no. 1, pp. 21–34, 2019.
  10. S. A. Lambert et al., “Towards clinical utility of polygenic risk scores,” Hum. Mol. Genet., vol. 28, no. R2, pp. R133–R142, 2019.
  11. C. Iyegbe et al., “The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research,” Soc Psychiatry Psychiatr Epidemiol, vol. 49, no. 2, pp. 169–182, 2014.
  12. K. Witkiewitz et al., “Mechanisms of behavior change in substance use disorder with and without formal treatment,” Annual Review of Clinical Psychology, vol. 18, pp. 497–525, 2022.
  13. M. Whitesell, A. Bachand, J. Peel, and M. Brown, “Familial, social, and individual factors contributing to risk for adolescent substance use,” Journal of addiction, vol. 2013, 2013.
  14. L. Canzian and M. Musolesi, “Trajectories of depression: unobtrusive monitoring of depressive states by means of smartphone mobility traces analysis,” in UbiComp.   ACM, 2015, pp. 1293–1304.
  15. A. A. Farhan et al., “Behavior vs. introspection: refining prediction of clinical depression via smartphone sensing data,” in 2016 IEEE wireless health (WH), IEEE.   IEEE, 2016, pp. 1–8.
  16. F. Ducci and D. Goldman, “The genetic basis of addictive disorders,” Psychiatric Clinics, vol. 35, no. 2, pp. 495–519, 2012.
  17. S. F. Butler et al., “Validation of a screener and opioid assessment measure for patients with chronic pain,” Pain, vol. 112, no. 1-2, pp. 65–75, Nov. 2004.
  18. M. O. Martel et al., “Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain,” Drug Alcohol Depend., vol. 132, no. 1-2, pp. 335–341, Sep. 2013.
  19. S. F. Butler et al., “Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R),” The Journal of Pain, vol. 9, no. 4, pp. 360–372, Apr. 2008.
  20. D. Koyyalagunta et al., “Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF,” Pain Medicine, vol. 14, no. 5, pp. 667–675, May 2013.
  21. D. C. Turk, K. S. Swanson, and R. J. Gatchel, “Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis,” The Clinical Journal of Pain, vol. 24, no. 6, pp. 497–508, Aug. 2008.
  22. W.-H. Lo-Ciganic et al., “Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions,” JAMA Network Open, vol. 2, no. 3, pp. e190 968–e190 968, Mar. 2019. [Online]. Available: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2728625
  23. S. Hassanpour et al., “Identifying substance use risk based on deep neural networks and Instagram social media data,” Neuropsychopharmacology, vol. 44, no. 3, p. 487, Feb. 2019. [Online]. Available: https://www.nature.com/articles/s41386-018-0247-x
  24. Z. Cheng et al., “Genome-wide association study identifies a regulatory variant of rgma associated with opioid dependence in european americans,” Biological psychiatry, vol. 84, no. 10, pp. 762–770, 2018.
  25. E. C. Nelson et al., “Evidence of CNIH3 involvement in opioid dependence,” Mol. Psychiatry, vol. 21, no. 5, pp. 608–614, May 2016.
  26. J. Gelernter et al., “Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways,” Biological Psychiatry, vol. 76, no. 1, pp. 66–74, Jul. 2014.
  27. D. Li et al., “Genome-wide association study of copy number variations (CNVs) with opioid dependence,” Neuropsychopharmacology, vol. 40, no. 4, pp. 1016–1026, Mar. 2015.
  28. S. E. McCabe et al., “Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence?” Addiction, vol. 102, no. 12, pp. 1920–1930, 2007.
  29. M. J. Edlund et al., “Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the troup study,” Drug Alcohol Depend., vol. 112, no. 1-2, pp. 90–98, 2010.
  30. J. L. Montalvo-Ortiz et al., “Genomewide study of epigenetic biomarkers of opioid dependence in european-american women,” Scientific reports, vol. 9, no. 1, pp. 1–9, 2019.
  31. B. N. Cochran et al., “Factors Predicting Development of Opioid Use Disorders among Individuals who Receive an Initial Opioid Prescription: Mathematical Modeling Using a Database of Commercially-insured Individuals,” Drug Alcohol Depend., vol. 138, pp. 202–208, May 2014. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046908/
  32. R. Chou, G. J. Fanciullo, P. G. Fine, J. A. Adler, J. C. Ballantyne, P. Davies, M. I. Donovan, D. A. Fishbain, K. M. Foley, J. Fudin et al., “Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain,” The Journal of Pain, vol. 10, no. 2, pp. 113–130, 2009.
  33. C. Yue et al., “Fusing location data for depression prediction,” IEEE Trans. Big Data, 2018.
  34. S. M. Phillips, L. Cadmus-Bertram, D. Rosenberg, M. P. Buman, and B. M. Lynch, “Wearable technology and physical activity in chronic disease: opportunities and challenges,” American journal of preventive medicine, vol. 54, no. 1, p. 144, 2018.
  35. S. Saeb et al., “Mobile Phone Sensor Correlates of Depressive Symptom Severity in Daily-Life Behavior: An Exploratory Study,” Journal of Medical Internet Research, vol. 17, no. 7, p. e175, Jul. 2015.
  36. A. Gruenerbl, V. Osmani, G. Bahle, J. C. Carrasco, S. Oehler, O. Mayora, C. Haring, and P. Lukowicz, “Using smart phone mobility traces for the diagnosis of depressive and manic episodes in bipolar patients,” in Proceedings of the 5th Augmented Human International Conference.   ACM, 2014, p. 38.
  37. R. Wang, F. Chen, Z. Chen, T. Li, G. Harari, S. Tignor, X. Zhou, D. Ben-Zeev, and A. T. Campbell, “Studentlife: assessing mental health, academic performance and behavioral trends of college students using smartphones,” in Proceedings of the 2014 ACM international joint conference on pervasive and ubiquitous computing.   ACM, 2014, pp. 3–14.
  38. D. Ben-Zeev, E. A. Scherer, R. Wang, H. Xie, and A. T. Campbell, “Next-Generation Psychiatric Assessment: Using Smartphone Sensors to Monitor Behavior and Mental Health,” Psychiatric rehabilitation journal, vol. 38, no. 3, pp. 218–226, Sep. 2015. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564327/
  39. Q. Wang and J. E. Taylor, “Patterns and Limitations of Urban Human Mobility Resilience under the Influence of Multiple Types of Natural Disaster,” PLOS ONE, vol. 11, no. 1, p. e0147299, Jan. 2016. [Online]. Available: https://dx.plos.org/10.1371/journal.pone.0147299
  40. N. Palmius et al., “Detecting Bipolar Depression From Geographic Location Data,” IEEE transactions on bio-medical engineering, vol. 64, no. 8, pp. 1761–1771, Aug. 2017. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947818/
  41. R. C. Smith, C. Frank, J. C. Gardiner, L. Lamerato, and K. M. Rost, “Pilot Study of a Preliminary Criterion Standard for Prescription Opioid Misuse,” The American Journal on Addictions, vol. 19, no. 6, pp. 523–528, 2010. [Online]. Available: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1521-0391.2010.00084.x
  42. P. B. Barr, M. N. Driver, S. I.-C. Kuo, M. Stephenson, F. Aliev, R. K. Linner, J. Marks, A. P. Anokhin, K. Bucholz, G. Chan et al., “Clinical, environmental, and genetic risk factors for substance use disorders: characterizing combined effects across multiple cohorts,” Molecular psychiatry, vol. 27, no. 11, pp. 4633–4641, 2022.
  43. S. Kinreich, J. L. Meyers, A. Maron-Katz, C. Kamarajan, A. K. Pandey, D. B. Chorlian, J. Zhang, G. Pandey, S. Subbie-Saenz de Viteri, D. Pitti et al., “Predicting risk for alcohol use disorder using longitudinal data with multimodal biomarkers and family history: a machine learning study,” Molecular psychiatry, vol. 26, no. 4, pp. 1133–1141, 2021.
  44. M. J. Dunning, M. L. Smith, M. E. Ritchie, and S. Tavaré, “beadarray: R classes and methods for illumina bead-based data,” Bioinformatics, vol. 23, no. 16, pp. 2183–2184, 2007.
  45. G. D. Evrony, A. G. Hinch, and C. Luo, “Applications of single-cell dna sequencing,” Annual review of genomics and human genetics, vol. 22, p. 171, 2021.
  46. S. Rinzivillo et al., “The purpose of motion: Learning activities from individual mobility networks,” in DSAA, IEEE.   IEEE, 2014, pp. 312–318.
  47. L.-A. McNutt, C. Wu, X. Xue, and J. P. Hafner, “Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes,” American Journal of Epidemiology, vol. 157, no. 10, pp. 940–943, May 2003, _eprint: https://academic.oup.com/aje/article-pdf/157/10/940/819150/kwg074.pdf. [Online]. Available: https://doi.org/10.1093/aje/kwg074
  48. F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel, M. Blondel, P. Prettenhofer, R. Weiss, V. Dubourg, J. Vanderplas, A. Passos, D. Cournapeau, M. Brucher, M. Perrot, and E. Duchesnay, “Scikit-learn: Machine learning in Python,” Journal of Machine Learning Research, vol. 12, pp. 2825–2830, 2011.
  49. E. Maloney, L. Degenhardt, S. Darke, R. P. Mattick, and E. Nelson, “Suicidal behaviour and associated risk factors among opioid-dependent individuals: A case–control study,” Addiction, vol. 102, no. 12, pp. 1933–1941, 2007.
  50. S. W. Choi, T. S.-H. Mak, and P. F. O’Reilly, “Tutorial: a guide to performing polygenic risk score analyses,” Nature Protocols, vol. 15, no. 9, pp. 2759–2772, Sep. 2020. [Online]. Available: https://doi.org/10.1038/s41596-020-0353-1
  51. E. Hastings and T. Burdett, “Gwas catalog,” GWAS catalog, 2017. [Online]. Available: https://www.ebi.ac.uk/gwas/home
  52. H.-P. K. Martin Ester, J. Sander, and X. Xu, “A density-based algorithm for discovering clusters in large spatial databases with noise,” in Proceedings of the Second International Conference on Knowledge Discovery and Data Mining, 1996, pp. 226–231.
  53. N. V. Chawla, K. W. Bowyer, L. O. Hall, and W. P. Kegelmeyer, “SMOTE: Synthetic minority over-sampling technique,” Journal of Artificial Intelligence Research, vol. 16, pp. 321–357, jun 2002. [Online]. Available: https://doi.org/10.1613%2Fjair.953
  54. S. M. Lundberg and S.-I. Lee, “A unified approach to interpreting model predictions,” in Advances in Neural Information Processing Systems 30.   Curran Associates, Inc., 2017, pp. 4765–4774.
  55. J. M. Vink, “Genetics of addiction: future focus on gene ×\times× environment interaction?” Journal of studies on alcohol and drugs, vol. 77, no. 5, pp. 684–687, 2016.
  56. M. Naveed, E. Ayday, E. W. Clayton, J. Fellay, C. A. Gunter, J.-P. Hubaux, B. A. Malin, and X. Wang, “Privacy in the genomic era,” ACM Computing Surveys (CSUR), vol. 48, no. 1, pp. 1–44, 2015.
  57. Y.-A. De Montjoye, C. A. Hidalgo, M. Verleysen, and V. D. Blondel, “Unique in the crowd: The privacy bounds of human mobility,” Scientific reports, vol. 3, no. 1, pp. 1–5, 2013.
  58. B. Berger and H. Cho, “Emerging technologies towards enhancing privacy in genomic data sharing,” Genome biology, vol. 20, no. 1, pp. 1–3, 2019.
  59. S. Chakraborty, K. R. Raghavan, M. P. Johnson, and M. B. Srivastava, “A framework for context-aware privacy of sensor data on mobile systems,” in Proceedings of the 14th Workshop on Mobile Computing Systems and Applications, 2013, pp. 1–6.
  60. B. H. Bornstein and A. C. Emler, “Rationality in medical decision making: a review of the literature on doctors’ decision-making biases,” Journal of evaluation in clinical practice, vol. 7, no. 2, pp. 97–107, 2001.
  61. N. Mehrabi, F. Morstatter, N. Saxena, K. Lerman, and A. Galstyan, “A survey on bias and fairness in machine learning,” ACM Computing Surveys (CSUR), vol. 54, no. 6, pp. 1–35, 2021.
  62. C. Rudin, C. Chen, Z. Chen, H. Huang, L. Semenova, and C. Zhong, “Interpretable machine learning: Fundamental principles and 10 grand challenges,” arXiv preprint arXiv:2103.11251, 2021.
  63. I. Lage, A. S. Ross, B. Kim, S. J. Gershman, and F. Doshi-Velez, “Human-in-the-loop interpretability prior,” Advances in neural information processing systems, vol. 31, 2018.
  64. G. Bansal, T. Wu, J. Zhou, R. Fok, B. Nushi, E. Kamar, M. T. Ribeiro, and D. Weld, “Does the whole exceed its parts? the effect of ai explanations on complementary team performance,” in Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems, 2021, pp. 1–16.
  65. B. H. Menze, B. M. Kelm, R. Masuch, U. Himmelreich, P. Bachert, W. Petrich, and F. A. Hamprecht, “A comparison of random forest and its gini importance with standard chemometric methods for the feature selection and classification of spectral data,” BMC bioinformatics, vol. 10, no. 1, pp. 1–16, 2009.
  66. A. Altmann, L. Tolosi, O. Sander, and T. Lengauer, “Permutation importance: a corrected feature importance measure,” Bioinformatics, vol. 26, no. 10, pp. 1340–1347, 2010.
  67. R. M. Byrne, “Counterfactuals in explainable artificial intelligence (xai): Evidence from human reasoning.” in IJCAI, 2019, pp. 6276–6282.
  68. U. Bhatt, A. Xiang, S. Sharma, A. Weller, A. Taly, Y. Jia, J. Ghosh, R. Puri, J. M. Moura, and P. Eckersley, “Explainable machine learning in deployment,” in Proceedings of the 2020 conference on fairness, accountability, and transparency, 2020, pp. 648–657.
  69. T. Cover and P. Hart, “Nearest neighbor pattern classification,” IEEE transactions on information theory, vol. 13, no. 1, pp. 21–27, 1967.
  70. A. Malinin, L. Prokhorenkova, and A. Ustimenko, “Uncertainty in gradient boosting via ensembles,” arXiv preprint arXiv:2006.10562, 2020.
  71. P. Köck and M. Walter, “Personality disorder and substance use disorder–an update,” Mental Health & Prevention, vol. 12, pp. 82–89, 2018.

Summary

No one has generated a summary of this paper yet.

Paper to Video (Beta)

No one has generated a video about this paper yet.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 1 tweet with 1 like about this paper.